全球迷走神经刺激市场

预计到 2030 年全球迷走神经刺激市场规模将达到 8.592 亿美元

全球迷走神经刺激市场规模预计在2024年为5.157亿美元，到2030年将达到8.592亿美元，在2024-2030年的分析期内，复合年增长率为8.9%。植入式迷走神经刺激装置是本报告分析的细分市场之一，预计其复合年增长率为7.7%，到分析期结束时规模将达到5.486亿美元。体外迷走神经刺激装置细分市场在分析期间的复合年增长率预计为11.2%。

美国市场预计将达到 1.405 亿美元，而中国市场预计将以 12.0% 的复合年增长率成长

美国迷走神经刺激市场规模预计2024年达到1.405亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到1.713亿美元，在2024-2030年的分析期间内，复合年增长率为12.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为6.4%和7.7%。在欧洲，预计德国市场的复合年增长率约为6.9%。

全球迷走神经刺激市场—主要趋势与驱动因素摘要

为什么迷走神经刺激处于神经调节突破的前沿？

迷走神经刺激 (VNS) 是神经调节领域的一种创新方法，近年来发展势头迅猛，为治疗复杂的神经和精神疾病带来了希望。 VNS 最初核准用于治疗难治性癫痫，后来治疗范围逐渐扩大到抗治疗性忧郁症、偏头痛、丛集性头痛，甚至发炎和心臟疾病。这种日益增长的临床多样性是由于迷走神经在整个自主神经系统中具有广泛的生理影响，使得 VNS 能够调节脑迴路、神经传导物质释放和发炎路径。现代 VNS 设备包括植入式和非侵入式系统，其中经皮VNS (tVNS) 因其易于使用和降低手术风险而越来越受欢迎。经皮VNS 透过耳朵或颈部的手术导线或电极向迷走神经传递受控电脉衝。随着越来越多的患者寻求非药物的长期治疗方法，VNS 已成为可行的解决方案，特别适用于慢性、抗治疗性疾病。随着临床证据的增多，越来越多的医生将迷走神经刺激 (VNS) 纳入多学科照护模式，随着治疗适应症的扩大，患者的兴趣也日益增长。这种转变凸显了迷走神经刺激 (VNS) 作为个人化神经标靶治疗支柱的重要性日益增强。

技术创新如何提高 VNS 设备的有效性和可近性？

技术进步在重新定义迷走神经刺激装置的功能和应用范围方面发挥着至关重要的作用。最新一代植入式迷走神经刺激系统 (VNS) 具有响应式（或闭合迴路）刺激功能，可根据心率和脑电图 (EEG) 数据等生理指标即时调整电脉衝。此类智慧型装置可改善治疗效果，同时最大限度地减少副作用，这是患者依从性的关键因素。非侵入式治疗方案，尤其是穿戴式迷走神经刺激系统 (tVNS)，为治疗方案带来了灵活性，减少了手术需求，并实现了居家治疗。电池寿命、装置可编程性和小型化的显着提升也提高了使用者的舒适度和便利性。与行动应用程式和云端基础分析的整合实现了远端监控、临床医生反馈和个人化给药方案，为持续护理模式打开了大门。一些 VNS 平台正在探索机器学习演算法，以根据患者的独特反应微调治疗参数。此外，与其他医疗技术（例如数位心理健康工具和睡眠监测应用程式）的互通性，正在为更全面的患者支援提供支援。这些创新正在将 VNS 从高度专业化的医院治疗方法转变为更广泛、更适应性强的解决方案，并且在门诊病人和远端医疗环境中的相关性越来越强。

监管部门的核准和研究管道在市场成熟度中将发挥什么作用？

围绕迷走神经刺激的监管和临床试验格局正在迅速发展，透过提高可靠性、检验和商业化机会来促进市场扩张。美国FDA 和欧洲 CE 标誌当局已经扩大了 VNS 设备对各种适应症的核准，并刺激了老牌医疗技术公司和新兴企业的创新。例如，非侵入性 VNS 设备已经进入头痛症市场，并获得了 PTSD 和发炎性肠道疾病疾病等疾病的突破性医疗设备称号。这些里程碑不仅证明了有效性和安全性，而且还支持加速进一步发展的道路。同时，一个强大的临床试验流程正在探索 VNS 在耳鸣、纤维肌痛、焦虑、类风湿性关节炎甚至与阿兹海默症相关的认知能力下降等疾病中的应用。这种不断扩大的潜在用途组合凸显了 VNS 疗法的适应性，并增强了其对投资者、医疗保健提供者和患者的价值提案。公共和私人对神经调节研究的资助也在增加，这促进了产学合作，旨在探索下一代迷走神经刺激 (VNS) 传输机制，包括生物电子植入和基因调控神经介面。随着这些研究的持续推进，由此产生的数据可能会巩固迷走神经刺激 (VNS) 在临床指南中的地位，鼓励扩大报销框架，并进一步刺激市场采用。

哪些因素推动了全球对迷走神经刺激解决方案的需求？

迷走神经刺激市场的成长受到多种因素的驱动，这些因素与技术进步、治疗多样化、治疗模式转变和病人参与提高直接相关。癫痫和忧郁症神经系统疾病在全球范围内的盛行率不断上升，尤其是在老化和抗治疗性人群中，这导致对无需药物负担即可长期缓解症状的替代疗法的需求持续增长。非侵入性迷走神经刺激设备的普及和接受度不断提高，降低了患者和医疗保健提供者的准入门槛，刺激了它们在门诊病人和居家医疗环境中的应用。生物电子医学和人们对迷走神经在发炎、压力和情绪中的调节作用的认识不断提高，也引起了临床和健康角度的新兴趣。医疗保健系统和保险公司正逐渐将神经调节视为一种具有成本效益的干预措施，尤其是在慢性药物治疗和住院治疗费用高昂的情况下。此外，个人化医疗趋势和数位健康工具的整合使患者能够更主动地管理治疗，而VNS平台也越来越多地提供即时数据和自适应治疗。医疗科技公司快速创新，加上良好的监管资格以及神经技术研究投入的不断增加，使其市场足迹不断扩展至北美、欧洲和亚太等快速成长的研发地区。综合来看，这些发展使VNS成为全球治疗领域强大且可扩展的解决方案。

部分

产品（植入式迷走神经刺激装置、体外迷走神经刺激装置）、生物材料（金属、陶瓷、聚合物）、应用（癫痫、忧郁症、偏头痛）、最终用途（医院、神经科诊所、门诊手术中心、研究中心）

受访公司范例

• BioControl Medical
• Boston Scientific Corporation
• Cirtec Medical
• Cyberonics, Inc.
• electroCore, Inc.
• Endonovo Therapeutics, Inc.
• EnteroMedics Inc.
• Helius Medical Technologies, Inc.
• Inspire Medical Systems, Inc.
• LivaNova PLC
• Masimo Corporation
• Medtronic plc
• MicroTransponder Inc.
• Nevro Corp.
• NeuroMetrix, Inc.
• NeuroPace, Inc.
• NeuroSigma, Inc.
• Parasym Ltd
• SetPoint Medical Corporation
• tVNS Health GmbH

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Vagus Nerve Stimulation Market to Reach US$859.2 Million by 2030

The global market for Vagus Nerve Stimulation estimated at US$515.7 Million in the year 2024, is expected to reach US$859.2 Million by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Implantable VNS Device, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$548.6 Million by the end of the analysis period. Growth in the External VNS Device segment is estimated at 11.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$140.5 Million While China is Forecast to Grow at 12.0% CAGR

The Vagus Nerve Stimulation market in the U.S. is estimated at US$140.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$171.3 Million by the year 2030 trailing a CAGR of 12.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Vagus Nerve Stimulation Market - Key Trends & Drivers Summarized

Why Is Vagus Nerve Stimulation at the Forefront of Neuromodulation Breakthroughs?

Vagus nerve stimulation (VNS) has gained critical momentum in recent years as a transformative approach within the broader field of neuromodulation, offering hope in the treatment of complex neurological and psychiatric conditions. Originally approved for refractory epilepsy, VNS has since expanded its therapeutic reach to include treatment-resistant depression, migraine, cluster headaches, and even promising applications in inflammatory diseases and cardiac disorders. This growing clinical versatility stems from the vagus nerve’s extensive physiological influence across the autonomic nervous system, enabling VNS to modulate brain circuits, neurotransmitter release, and inflammatory pathways. Modern VNS devices include both implantable and non-invasive systems, with transcutaneous VNS (tVNS) gaining favor for its ease of use and reduced procedural risks. These devices deliver controlled electrical impulses to the vagus nerve, either via surgical leads or external ear or neck-based electrodes. With an increasing number of patients seeking drug-free, long-term alternatives to conventional treatments, VNS has emerged as a viable solution, particularly in chronic and treatment-resistant conditions. As the body of clinical evidence grows, more physicians are integrating VNS into multidisciplinary care models, and patient interest is rising in parallel with expanded therapeutic indications. This shift underscores the growing importance of VNS as a pillar of personalized, neuro-targeted medicine.

How Are Technological Innovations Enhancing the Efficacy and Accessibility of VNS Devices?

Technological advancements are playing a decisive role in redefining the capabilities and reach of vagus nerve stimulation devices. The latest generation of implantable VNS systems now feature responsive or closed-loop stimulation, allowing real-time adaptation of electrical pulses based on physiological markers such as heart rate or electroencephalographic data. These intelligent devices improve therapeutic outcomes while minimizing side effects, a crucial factor in patient adherence. Non-invasive options, particularly tVNS wearables, have introduced flexibility in treatment schedules, reducing the need for surgery and enabling at-home therapy. Battery life, device programmability, and miniaturization have also seen significant improvements, contributing to enhanced comfort and convenience for users. Integration with mobile applications and cloud-based analytics allows remote monitoring, clinician feedback, and individualized dosing regimens, opening doors for continuous care models. Some VNS platforms are exploring machine learning algorithms to fine-tune therapy parameters based on patient-specific responses. Additionally, device interoperability with other health technologies, such as digital mental health tools or sleep monitoring apps, is enabling more holistic patient support. These innovations are transforming VNS from a highly specialized hospital-based therapy into a broader, more adaptable solution with growing relevance in both outpatient and telehealth environments.

What Role Do Regulatory Approvals and Research Pipelines Play in Market Maturation?

The regulatory and clinical trial landscape surrounding vagus nerve stimulation is rapidly evolving, fostering market expansion through increased trust, validation, and commercialization opportunities. The U.S. FDA and European CE Mark authorities have broadened approval for VNS devices across various indications, encouraging innovation among both established medtech companies and start-ups. For instance, non-invasive VNS devices have gained market entry for headache disorders and have received Breakthrough Device Designation for conditions such as PTSD and inflammatory bowel disease. These milestones not only validate efficacy and safety but also support accelerated pathways for further development. Concurrently, a robust pipeline of clinical trials is exploring VNS applications in disorders such as tinnitus, fibromyalgia, anxiety, rheumatoid arthritis, and even cognitive decline linked to Alzheimer's disease. This expanding portfolio of potential uses underscores the adaptability of VNS therapy and enhances its value proposition to investors, healthcare providers, and patients. Public and private funding for neuromodulation research is also growing, fueling academic-industry collaborations aimed at exploring next-gen VNS delivery mechanisms, including bioelectronic implants and gene-modulated neural interfaces. As these developments continue, the resulting data will solidify the role of VNS in clinical guidelines and encourage reimbursement frameworks to widen, further stimulating market adoption.

What Factors Are Driving the Global Demand for Vagus Nerve Stimulation Solutions?

The growth in the vagus nerve stimulation market is driven by several factors directly linked to technological advancements, therapeutic diversification, changing treatment paradigms, and increasing patient engagement. The rising global incidence of neurological disorders such as epilepsy and depression-especially among aging and treatment-resistant populations-is creating sustained demand for alternative therapies that offer long-term relief without pharmacological burden. The expanding availability and acceptance of non-invasive VNS devices have lowered the entry barrier for patients and providers alike, fueling adoption across outpatient and home care settings. Increased awareness of bioelectronic medicine and the vagus nerve’s regulatory role in inflammation, stress, and mood is also attracting new interest from both clinical and wellness perspectives. Healthcare systems and insurers are gradually aligning with neuromodulation as a cost-effective intervention, especially in cases where chronic medication and hospitalization costs are high. Furthermore, personalized medicine trends and the integration of digital health tools are empowering patients to manage their treatment more proactively, with VNS platforms increasingly offering real-time data and adaptive therapy. Rapid innovation from medtech companies, combined with favorable regulatory designations and growing investment in neurotechnology research, is expanding the market footprint across North America, Europe, and rapidly developing regions like Asia-Pacific. Collectively, these dynamics are positioning VNS as a powerful, scalable solution within the global therapeutic landscape.

SCOPE OF STUDY:

The report analyzes the Vagus Nerve Stimulation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Implantable VNS Device, External VNS Device); Biomaterial (Metallic, Ceramics, Polymeric); Application (Epilepsy, Depression, Migraine); End-Use (Hospitals, Neurology Clinics, Ambulatory Surgery Centers, Research Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• BioControl Medical
• Boston Scientific Corporation
• Cirtec Medical
• Cyberonics, Inc.
• electroCore, Inc.
• Endonovo Therapeutics, Inc.
• EnteroMedics Inc.
• Helius Medical Technologies, Inc.
• Inspire Medical Systems, Inc.
• LivaNova PLC
• Masimo Corporation
• Medtronic plc
• MicroTransponder Inc.
• Nevro Corp.
• NeuroMetrix, Inc.
• NeuroPace, Inc.
• NeuroSigma, Inc.
• Parasym Ltd
• SetPoint Medical Corporation
• tVNS Health GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Vagus Nerve Stimulation - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Neurological and Psychiatric Disorders Drives Demand for Vagus Nerve Stimulation Therapies
  • Expansion of Non-Invasive VNS Devices Spurs Growth in At-Home and Outpatient Treatment Adoption
  • Advancements in Closed-Loop and Responsive Stimulation Technologies Strengthen the Business Case for Smart VNS Systems
  • FDA Approvals and Breakthrough Device Designations Propel Market Expansion Across New Therapeutic Indications
  • Growing Use of VNS in Treatment-Resistant Depression and Epilepsy Sustains Long-Term Market Growth
  • Integration of VNS With Wearables and Mobile Health Apps Generates Opportunities for Remote Monitoring Solutions
  • Increased Focus on Bioelectronic Medicine Throws the Spotlight on VNS as a Pillar of Neuromodulation Therapies
  • Consumer Preference for Drug-Free Chronic Condition Management Drives Adoption of Implant-Free VNS Alternatives
  • Emerging Applications in Cognitive Health and PTSD Generate Demand for Specialized VNS Protocols
  • Increasing Awareness of the Gut-Brain Axis and Autonomic Nervous System Function Enhances Interest in VNS Therapies
  • Global Aging Population and Rise in Neurodegenerative Diseases Create Sustainable Demand for VNS Interventions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Vagus Nerve Stimulation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Implantable VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Implantable VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Implantable VNS Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for External VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for External VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for External VNS Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Neurology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Neurology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Neurology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Metallic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Ceramics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Polymeric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Polymeric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Polymeric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• JAPAN
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• CHINA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• EUROPE
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Vagus Nerve Stimulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• FRANCE
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• GERMANY
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 140: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• INDIA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 215: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Vagus Nerve Stimulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Vagus Nerve Stimulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
• AFRICA
  • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030

IV. COMPETITION